Binimetinib
Jump to navigation
Jump to search
| Binimetinib | |
|---|---|
| Term | Binimetinib |
| Short definition | Binimetinib - (pronounced) (BIH-nee-MEH-tih-nib) medicine used with encorafenib to treat melanoma that has spread or cannot be surgically removed and has a specific mutation (change) in the melanomaBRAFGen. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Binimetinib - (pronounced) (BIH-nee-MEH-tih-nib) medicine used with encorafenib to treat melanoma that has spread or cannot be surgically removed and has a specific mutation (change) in the melanomaBRAFGen. It is also being studied in the treatment of other types of cancer. Binimetinib blocks the proteins MEK1 and MEK2, which can help prevent cancer cells from growing. It's a kind of kinase inhibitor. Also called Mektovi
External links
- Medical encyclopedia article on Binimetinib
- Wikipedia's article - Binimetinib
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski